Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
EarlySight logo — See the invisible

EarlySight

See the invisible

Founded 2019 Switzerland Geneva, Switzerland 10 employees Seed Total: $2.81M Health Care

General Information

Company Name EarlySight
Founded Year 2019
Location Switzerland Geneva, Switzerland
Employees 10
Industries Health Care
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with EarlySight. To contact EarlySight, visit earlysight.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does EarlySight compare?

A PDF of EarlySight and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting EarlySight soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About EarlySight

EarlySight, founded in 2019 and headquartered in Switzerland, has recently secured a noteworthy €2.70M Seed Round investment on 26 May 2021 from Verve Ventures and Nina Ventures. The startup's vision is to "See the invisible," aiming to combat vision loss by enhancing the detection and monitoring of eye diseases. EarlySight's breakthrough lies in the development of a high-performance eye imaging instrument that enables ophthalmologists to visualize the morphology of previously invisible cells in the retina, which play critical roles in degenerative eye diseases. The company's technology is poised to significantly enhance the detection and monitoring of various conditions like age-related macular degeneration. It promises to provide quantitative evidence of treatment efficacy and accelerate the development of new therapies. Furthermore, EarlySight's innovative approach allows for non-invasive assessment of retinal health and swift monitoring of treatment effects, eliminating the need to wait for months to observe changes in visual acuity. Overall, EarlySight's recent funding injection and pioneering approach in leveraging technology to revolutionize ophthalmic care demonstrate its potential to make substantial strides in addressing and combating vision-related health issues within the Health Care industry.

Business keywords: ophthalmology, vision, eye imaging, retina health, disease detection, treatment monitoring, innovation, clinical development, ophthalmic instruments, disease monitoring, age-related macular degeneration, treatment efficacy, therapies

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round €2.70M 2
Verve Ventures Nina Ventures
Verve Ventures, Nina Ventures
26 May 2021
Non Equity Assistance Undisclosed 1
MassChallenge
MassChallenge
21 Oct 2020
Pre Seed Round Undisclosed 1
Nina Ventures
Nina Ventures
30 Aug 2020
Grant Fr.10.00K 1
Venture Kick
Venture Kick
10 Mar 2020
Debt Financing Fr.100.00K 1
Foundation for Technological Innovation (FIT)
28 Feb 2020

EarlySight Alternatives & Competitors

View All Alternatives
EarlySight vs
Optos
Optos United Kingdom

Proud to be recognized as a leading provider of devices to eye care professionals.

Acquired
810 employees
Health Care, Health and Wellness
EarlySight vs
ONL Therapeutics
ONL Therapeutics United States

Helping patients see the future

Venture round
39 employees
Biotechnology, Health Care
EarlySight vs
TelomEYE Pharmaceutical Corporation
TelomEYE Pharmaceutical Corporation Canada

TelomEYE is developing innovative treatments to prevent, delay and cure age-related conditions of th...

Seed
2 employees
Health Care
View all alternatives

FAQ About EarlySight

See the invisible
EarlySight was founded in 2019.
EarlySight is headquartered in Geneva, Switzerland.
EarlySight operates in Health Care. Its work centres on ophthalmology, vision, eye imaging and retina health.
EarlySight has approximately 10 employees.
EarlySight has completed 5 funding rounds, raising a total of $2.81M. The latest funding stage is Seed.
Top alternatives and competitors to EarlySight include Optos, ONL Therapeutics, TelomEYE Pharmaceutical Corporation, LambdaVision, Inc., Acuity Pharmaceuticals. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
EarlySight and Optos are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for EarlySight, https://bouncewatch.com/company/earlysight, updated 24 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout